Payment overview · 2025
General Payments
$317.06
12 reported records · 8 companies
Healthcare provider profile · identity verified
Stephen H Nguyen, MD
Allopathic & Osteopathic Physicians|Internal Medicine · SUN CITY, CA · NPI 1619976644
Verified facts
What the public records show
CMS Open Payments records show Stephen H Nguyen, MD received $317.06 in general payments during 2025 across 12 reported records.
Corcept Therapeutics accounted for 35.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 10 associated products.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 79 claims for Farxiga by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Corcept Therapeutics | Unresolved — no canonical attribution shown | $112.56 | 35.5% | 1 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $46.07 | 14.5% | 3 | 2025 |
| Intra-Sana Laboratories | Unresolved — no canonical attribution shown | $33.74 | 10.6% | 2 | 2025 |
| Eisai Inc. | Unresolved — no canonical attribution shown | $31.06 | 9.8% | 1 | 2025 |
| Almatica Pharma LLC | Unresolved — no canonical attribution shown | $25.88 | 8.2% | 1 | 2025 |
| Electromed, Inc. | Unresolved — no canonical attribution shown | $24.93 | 7.9% | 2 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $22.44 | 7.1% | 1 | 2025 |
| Esperion Therapeutics, Inc. | Unresolved — no canonical attribution shown | $20.38 | 6.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $317.06 | 12 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Korlym Normalized: korlym |
Drug | Corcept Therapeutics | $112.56 | 1 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $46.07 | 3 | 2025 |
Source payment records
|
|||||
| GLYCATE Normalized: glycate |
Drug | Intra-Sana Laboratories | $33.74 | 2 | 2025 |
Source payment records
|
|||||
| RELTONE 200 MG Normalized: reltone 200 mg |
Drug | Intra-Sana Laboratories | $33.74 | 2 | 2025 |
Source payment records
|
|||||
| RELTONE 400 MG Normalized: reltone 400 mg |
Drug | Intra-Sana Laboratories | $33.74 | 2 | 2025 |
Source payment records
|
|||||
| Leqembi Normalized: leqembi |
Drug | Eisai Inc. | $31.06 | 1 | 2025 |
Source payment records
|
|||||
| LOREEV XR Normalized: loreev xr |
Drug | Almatica Pharma LLC | $25.88 | 1 | 2025 |
Source payment records
|
|||||
| SMARTVEST Normalized: smartvest |
Device | Electromed, Inc. | $24.93 | 2 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $22.44 | 1 | 2025 |
Source payment records
|
|||||
| NEXLETOL Normalized: nexletol |
Drug | Esperion Therapeutics, Inc. | $20.38 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
79 | 19 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 823 | 242 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 778 | 230 |
| Levothyroxine Sodium | Levothyroxine Sodium | 625 | 169 |
| Amlodipine Besylate | Amlodipine Besylate | 411 | 128 |
| Tamsulosin Hcl | Tamsulosin Hcl | 300 | 94 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 296 | 103 |
| Metoprolol Succinate | Metoprolol Succinate | 256 | 78 |
| Lisinopril | Lisinopril | 249 | 75 |
| Ezetimibe | Ezetimibe | 243 | 73 |
| Gabapentin | Gabapentin | 233 | 62 |
| Pantoprazole Sodium | Pantoprazole Sodium | 226 | 67 |
| Zolpidem Tartrate | Zolpidem Tartrate | 224 | 42 |
| Alprazolam | Alprazolam | 222 | 55 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 221 | 63 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 200 | 42 |
| Metformin Hcl | Metformin Hcl | 199 | 65 |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 168 | 53 |
| Trazodone Hcl | Trazodone Hcl | 160 | 40 |
| Furosemide | Furosemide | 159 | 52 |
| Omeprazole | Omeprazole | 158 | 45 |
| Losartan Potassium | Losartan Potassium | 156 | 52 |
| Donepezil Hcl | Donepezil Hcl | 155 | 49 |
| Clopidogrel | Clopidogrel Bisulfate | 154 | 47 |
| Carvedilol | Carvedilol | 150 | 38 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 145 | 55 |
| Duloxetine Hcl | Duloxetine Hcl | 142 | 44 |
| Eliquis | Apixaban | 140 | 46 |
| Alendronate Sodium | Alendronate Sodium | 132 | 46 |
| Famotidine | Famotidine | 127 | 37 |
| Lorazepam | Lorazepam | 124 | 22 |
| Ozempic | Semaglutide | 121 | 20 |
| Ibuprofen | Ibuprofen | 117 | 26 |
| Allopurinol | Allopurinol | 116 | 33 |
| Ipratropium Bromide | Ipratropium Bromide | 107 | 44 |
| Escitalopram Oxalate | Escitalopram Oxalate | 95 | 30 |
| Spironolactone | Spironolactone | 94 | 31 |
| Hydrochlorothiazide | Hydrochlorothiazide | 92 | 31 |
| Synthroid | Levothyroxine Sodium | 92 | 22 |
| Telmisartan | Telmisartan | 87 | 28 |
| Farxiga | Dapagliflozin Propanediol | 79 | 19 |
| Potassium Chloride | Potassium Chloride | 79 | 25 |
| Meloxicam | Meloxicam | 78 | 25 |
| Metformin Hcl Er | Metformin Hcl | 78 | 32 |
| Clonazepam | Clonazepam | 77 | 14 |
| Prednisone | Prednisone | 73 | 31 |
| Jardiance | Empagliflozin | 72 | 21 |
| Pioglitazone Hcl | Pioglitazone Hcl | 71 | 20 |
| Atenolol | Atenolol | 69 | 20 |
| Valsartan | Valsartan | 69 | 18 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 68 | 27 |
| Temazepam | Temazepam | 68 | suppressed |
| Azithromycin | Azithromycin | 67 | 63 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 67 | 43 |
| Tramadol Hcl | Tramadol Hcl | 67 | 22 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 66 | 25 |
| Benazepril Hcl | Benazepril Hcl | 63 | 19 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 63 | 14 |
| Diazepam | Diazepam | 62 | 12 |
| Irbesartan | Irbesartan | 62 | 20 |
| Finasteride | Finasteride | 61 | 21 |
| Mirtazapine | Mirtazapine | 61 | 17 |
| Montelukast Sodium | Montelukast Sodium | 61 | 18 |
| Pregabalin | Pregabalin | 58 | 16 |
| Memantine Hcl | Memantine Hcl | 56 | 22 |
| Sertraline Hcl | Sertraline Hcl | 56 | 17 |
| Pravastatin Sodium | Pravastatin Sodium | 55 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 53 | 21 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 53 | 15 |
| Glipizide | Glipizide | 52 | 17 |
| Nebivolol Hcl | Nebivolol Hcl | 51 | 20 |
| Diclofenac Sodium | Diclofenac Sodium | 49 | 18 |
| Nateglinide | Nateglinide | 46 | 11 |
| Xarelto | Rivaroxaban | 44 | 14 |
| Clonidine Hcl | Clonidine Hcl | 43 | 22 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 41 | 29 |
| Hydralazine Hcl | Hydralazine Hcl | 40 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 40 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 40 | suppressed |
| Mounjaro | Tirzepatide | 39 | suppressed |
| Ramipril | Ramipril | 39 | 12 |
| Metoprolol Tartrate | Metoprolol Tartrate | 37 | 14 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 37 | 13 |
| Sildenafil Citrate | Sildenafil Citrate | 37 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 36 | 12 |
| Simvastatin | Simvastatin | 35 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 34 | 13 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 34 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 32 | suppressed |
| Glipizide Er | Glipizide | 31 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 31 | suppressed |
| Baclofen | Baclofen | 30 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 30 | suppressed |
| Celecoxib | Celecoxib | 30 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 30 | 23 |
| Latanoprost | Latanoprost | 29 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 29 | 13 |
| Vascepa | Icosapent Ethyl | 29 | suppressed |
| Bupropion Xl | Bupropion Hcl | 28 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | suppressed |
| Januvia | Sitagliptin Phosphate | 28 | suppressed |
| Sulindac | Sulindac | 28 | 11 |
| Chlorthalidone | Chlorthalidone | 27 | suppressed |
| Glimepiride | Glimepiride | 27 | suppressed |
| Lamotrigine | Lamotrigine | 27 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 27 | 27 |
| Tacrolimus | Tacrolimus | 25 | suppressed |
| Trulicity | Dulaglutide | 25 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 24 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 23 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 23 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 22 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 22 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 22 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 21 |
| Dutasteride | Dutasteride | 21 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 21 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 20 | suppressed |
| Digoxin | Digoxin | 20 | suppressed |
| Febuxostat | Febuxostat | 20 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 20 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 20 | 12 |
| Memantine Hcl Er | Memantine Hcl | 20 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 20 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 20 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 19 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 19 | 14 |
| Invokana | Canagliflozin | 18 | suppressed |
| Livalo | Pitavastatin Calcium | 18 | suppressed |
| Methylprednisolone | Methylprednisolone | 18 | 16 |
| Acyclovir | Acyclovir | 17 | suppressed |
| Bumetanide | Bumetanide | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Estradiol | Estradiol | 16 | suppressed |
| Eszopiclone | Eszopiclone | 16 | suppressed |
| Folic Acid | Folic Acid | 16 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Cephalexin | Cephalexin | 15 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 15 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Eplerenone | Eplerenone | 14 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | 11 |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 14 | suppressed |
| Amlodipine-Atorvastatin | Amlodipine/Atorvastatin | 13 | suppressed |
| Colchicine | Colchicine | 13 | suppressed |
| Humira | Adalimumab | 13 | suppressed |
| Humulin R | Insulin Regular, Human | 13 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 13 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 12 | suppressed |
| Entresto | Sacubitril/Valsartan | 12 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 12 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 12 | suppressed |
| Klor-Con 10 | Potassium Chloride | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Levetiracetam | Levetiracetam | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | suppressed |
| Nucynta | Tapentadol Hcl | 12 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 12 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 11 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 11 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 11 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 11 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $317.06 · 12 records | Corcept Therapeutics | AIRSUPRA, GLYCATE, Korlym, LOREEV XR, Leqembi, NEXLETOL, RELTONE 200 MG, RELTONE 400 MG, SMARTVEST, The Cologuard Plus Collection Kit | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error